PTPN22 and type 1 diabetes mellitus: In addition, we need to combine basic research with clinical disease to explore how the effects of PTPN22 on T cell development regulate the pathogenesis of autoimmune diseases such as type 1 diabetes, systemic lupus erythematosus, and rheumatoid arthritis.